ForumIAS LATEST
- SFG FRC 2027 | Program starts from 19th Dec. 2026 | Admissions open for Entrance Test Click Here to know more →
- Prelims Test Series (PTS) for Prelims 2027 starts 11th Oct. 2026 Click Here to know more →
- [Pre-order] Ethics Redbook 3rd Edition: Delivery starts from 10th October onwards Click Here to Read More →
- 21 Sept. | GS Advance Program (GSAP) for UPSC 2027 Mains starts from 11th Oct. Click Here to Read More →
News: The Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) test, powered by CSIR-IGIB (Institute of Genomics and Integrative Biology) FELUDA, received regulatory approvals from the Drug Controller General of India (DCGI) for commercial launch.
Facts:
- FELUDA is the acronym for FNCAS9 Editor Linked Uniform Detection Assay. It is a low cost paper strip test which can detect the presence of coronavirus within an hour.
- It uses indigenously developed CRISPR gene-editing technology to identify and target the genetic material of SARS-CoV2.
Additional Information:
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)
- It is a gene editing technology. It can detect specific sequences of DNA within a gene and uses an enzyme functioning as molecular scissors to snip it.
- It is used in correcting genetic defects and treating and preventing the spread of diseases.
